Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.
Blueprint Medicines stock last closed at $93.00, up 2.5% from the previous day, and has increased 89.72% in one year. It has overperformed other stocks in the Biotechnology industry by 1.12 percentage points. Blueprint Medicines stock is currently +111.89% from its 52-week low of $43.89, and -7.92% from its 52-week high of $101.00.
At the moment, there are 61.23M shares of BPMC outstanding. The market capitalization of BPMC is $5.69B. In the past 24 hours, 725,952 BPMC shares were traded.
How to Buy Blueprint Medicines Stock
Not sure how to invest in Blueprint Medicines stock? Here's how.
Figure out where to buy Blueprint Medicines stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you choose where to buy Blueprint Medicines stock.
Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Fund your investment account: Choose your method of payment and add your details.
Analyze Blueprint Medicines stock: The Blueprint Medicines ticker symbol is BPMC. Is Blueprint Medicines stock a good investment? Should you buy shares of BPMC? How do BPMC's underlying business fundamentals look? Do top analysts think Blueprint Medicines is a good buy? Why has BPMC's stock price moved recently? (Hint: Our stock research tools can help you figure out if BPMC is a good stock to buy).
Make your BPMC buy order: Decide if you will purchase BPMC shares at the current market price or use a limit order to buy BPMC shares at a particular price.
Keep an eye on your investment in BPMC: Create a watchlist to important updates regarding your new investment in Blueprint Medicines stock.
Step 1: Figure out where to buy Blueprint Medicines stock
You need a brokerage account in order to access the NASDAQ market and buy BPMC shares.
A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to world markets: From Technology to Utilities, New York to London — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal information so you are able to buy BPMC stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Blueprint Medicines stock
Once you have identified the best place to buy Blueprint Medicines stock, it's absolutely critical to analyze their stock before you invest, so you actually wrap your head around the risk as well as the opportunity.
Blueprint Medicines stock quick numbers
BPMC Price
$93.00
1w %
7.08%
1y %
89.72%
5y %
21%
P/E
-11.11x
P/B
43.6x
P/S
22.58x
PEG
N/A
Revenue
$249.38M
Earnings
-$506.98M
Fore. Rev. Growth
44.36%
Fore. Earn. Growth
N/A
Market Cap
$5.69B
Next Earnings
Jun 12, 2024
Next Dividend
N/A
Blueprint Medicines Due Diligence Checks
WallStreetZen was designed to help everyday investors perform better fundamental analysis.
BPMC has $720.88M in cash and short term investments. This is enough to cover its annual cash burn of $452.91M.
There are more short-term assets than long-term liabilities on the BPMC balance sheet.
BPMC has cash burn of 452909000. It has sufficient cash and short-term investments to cover this for at least one year.
There are more short-term assets than short-term liabilities on the BPMC balance sheet.
Cons:
Total BPMC debt is higher than 5 years ago, relative to shareholder equity.
BPMC has a relatively high debt to equity ratio of 7.03.
BPMC profit margin has gone up by 0.7 percentage points in the past year, but the company is still unprofitable.
Do Wall Street analysts think it's a good time to buy Blueprint Medicines stock
Out of 11 sell side analysts who track BPMC, the consensus analyst rating on Blueprint Medicines is a Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
Latest BPMC Analyst Ratings
David Lebovitz, a bottom 9% analyst from Citigroup maintains BPMC with a strong sell rating and raises their BPMC price target from $54.00 to $65.00, on Feb 16, 2024.
Peter Lawson, a top 24% analyst from Barclays maintains BPMC with a hold rating and raises their BPMC price target from $58.00 to $70.00, on Feb 13, 2024.
Dane Leone, a bottom 4% analyst from Raymond James maintains BPMC with a strong buy rating and raises their BPMC price target from $85.00 to $100.00, on Dec 22, 2023.
Derek Archila, a top 3% analyst from Wells Fargo maintains BPMC with a strong buy rating and raises their BPMC price target from $86.00 to $115.00, on Dec 19, 2023.
Matthew Biegler, a bottom 11% analyst from Oppenheimer upgrades BPMC to a buy rating and announces their BPMC price target of $85.00, on Oct 27, 2023.
Last year, BPMC revenue was $249.38M. In the past five year, BPMC's revenue has grown by 41.14% per year. This was faster than the Biotechnology industry average of 28.56%.
No, Blueprint Medicines doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your BPMC buy order
You have two main options:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are generally fine.
Limit order: A limit order enables you to buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at an exact price, place a limit order.
Click the Open Trade button and eToro will place the order.
If you want additional help investing in stocks on eToro, watch the helpful video below:
How much does it cost to buy one Blueprint Medicines share?
As of Apr 26, 2024, it costs $93.00 to buy one share of Blueprint Medicines stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.108 shares of BPMC.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.